Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics
Pleuroparenchymal fibroelastosis (PPFE) is an unusual pulmonary disease with unique
clinical, radiological, and pathological characteristics. Designated a rare idiopathic …
clinical, radiological, and pathological characteristics. Designated a rare idiopathic …
[HTML][HTML] The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative review
S Morita-Tanaka, T Yamada… - Translational Lung Cancer …, 2023 - ncbi.nlm.nih.gov
The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative
review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
[HTML][HTML] Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons
M Koureas, P Kirgou, G Amoutzias… - Metabolites, 2020 - mdpi.com
The aim of the present study was to investigate the ability of breath analysis to distinguish
lung cancer (LC) patients from patients with other respiratory diseases and healthy people …
lung cancer (LC) patients from patients with other respiratory diseases and healthy people …
Frailty as a predictor of mortality in patients with interstitial lung disease referred for lung transplantation
E Montgomery, PS Macdonald, PJ Newton… - …, 2020 - journals.lww.com
Background. Frailty is a clinically recognized syndrome of decreased physiological reserve
and a key contributor to suboptimal clinical outcomes in various lung disease groups …
and a key contributor to suboptimal clinical outcomes in various lung disease groups …
Geriatric nutritional risk index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis
Y Mochizuka, Y Suzuki, M Kono, H Hasegawa… - …, 2023 - Wiley Online Library
Abstract Background and Objective Idiopathic pulmonary fibrosis (IPF) is characterized by
progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested …
progressive lung fibrosis of unknown aetiology. Epidemiological studies have suggested …
[HTML][HTML] Nutrition in patients with idiopathic pulmonary fibrosis: critical issues analysis and future research directions
P Faverio, M Bocchino, A Caminati, A Fumagalli… - Nutrients, 2020 - mdpi.com
In idiopathic pulmonary fibrosis (IPF), several factors may have a negative impact on the
nutritional status, including an increased respiratory muscles load, release of inflammation …
nutritional status, including an increased respiratory muscles load, release of inflammation …
[HTML][HTML] Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis
A Nakano, H Ohkubo, H Taniguchi, Y Kondoh… - Scientific reports, 2020 - nature.com
Computed tomography (CT) assessment of the cross-sectional area of the erector spinae
muscles (ESMCSA) can be used to evaluate sarcopenia and cachexia in patients with lung …
muscles (ESMCSA) can be used to evaluate sarcopenia and cachexia in patients with lung …
[HTML][HTML] Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study
Background Patients with fibrotic interstitial lung disease (ILD) are frequently physically
inactive and many ILD subtypes are characterized by risk factors for myopathy; however, the …
inactive and many ILD subtypes are characterized by risk factors for myopathy; however, the …
[HTML][HTML] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy
Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …